Haff disease in the pandemic COVID-19 period in Brazil
DOI:
https://doi.org/10.33448/rsd-v10i14.22175Keywords:
Haff disease; Haff disease; Rhabdomyolysis; Toxins; Rhabdomyolysis; Toxins.Abstract
Objective: This study describes and characterize the cases of Haff disease reported in Brazil during the COVID-19 pandemic period. Descriptive and cross-sectional study using public data from the National Center for Strategic Information and Response in Health Surveillance nacional. The Risk Communication number 17 of 09/15/2021 was accessed. The description of suspected cases was extended to all Brazilian states where notifications occurred, from January 1, 2020, to September 15, 2021. There was an increase in cases of Haff's disease in Brazil, from 2020 onwards, with 46 in the Northeast region of Brazil. Eighty-five cases and three deaths were reported between January and September 2021 in the North, Northeast, South and Midwest regions. Most cases occurred in regions of greater heat such as the coastal region of the Northeast and around regions of the Amazon River Basin. A critical period for coping with the SARS-CoV-2 virus pandemic in Brazil, cases of disease of Haff could be reported in various regions of country. Despite the etiological suspicions, studies, and follow-up of the cases, it is still not possible to affirm that the disease is caused by biomolecules of the Palytoxin-Like Toxins group. The possible identification of the responsible toxin(s) will be essential for a complete understanding of the etiopathogenic mechanism of the disease and adequate development of prevention, treatment, and cure measures.
References
Bandeira, A.C.; Campos, G.S.; Ribeiro, G.S.; Cardoso, C.W.; Bastos, C.J.; Pessoa, T.L.; Araujo, K.A.; Grassi, M.F.R.; Castro, A.P.; Carvalho, R.H.; Prates, A.P.P.B.; Gois, L.L.; Rocha, V.F.; Sardi, S.I. (2017). Clinical and laboratory evidence of Haff disease – case series from an outbreak in Salvador, Brazil, December 2016 to April 2017. Euro Surveillance, 22, 30552. Doi: http://dx.doi.org/10.2807/1560-7917.ES.2017.22.24.30552.
Boente-Juncal, A.; Raposo-García, S.; Vale, C.; Louzao, M.C.; Otero, P.; Botana, L.M. (2020). In vivo evaluation of the chronic oral toxicity of the marine toxin palytoxin. Toxins, 12, 489. Doi:10.3390/toxins12080489.
Boente-Juncal, A.; Vale, C.; Camiña, M.; Cifuentes, J.M.; Vieytes, M.R.; Botana, L.M. (2020). Reevaluation of the acute toxicity of palytoxin in mice: Determination of lethal dose 50 (LD50) and No-observed-adverse-effect level (NOAEL). Toxicon, 177, 16–24.
Buchholz U, Mouzin E, Dickey R, et al. (2000). Haff disease: from the Baltic Sea to the U.S. shore. Emerg Infect Dis, 6, 192−5.
Caixin L, Peng L, Xueqian W, et al. (2017). Epidemiology and laboratory characteristics of 102 cases of crayfish caused by rhabdomyolysis. J Yichun University, 9, 62−4. (In Chinese)
Cardoso, L.S.; Torgan, L.C. (2007). Dinoflagelados em diversos habitats e hidroperíodos na zona costeira do sul do Brasil. Acta Botanica Brasileira, 21, 411-419.
Chen Y, Yuan B, Xie G, et al. (2016). Outbreak of Haff Disease caused by consumption of crayfish (Procambarus clarkii), Nanjing, Jiangsu Province, China. Food Control, 59, 690−4.
Diaz, J.H. (2015). Global incidence of rhabdomyolysis after cooked seafood consumption (Haff disease). Clinical Toxicology, 53, 421–426.
dos Santos MC, de Albuquerque BC, Pinto RC, Aguiar GP, Lescano AG, Santos JH, et al. (2009). Outbreak of Haff disease in the Brazilian Amazon. Rev Panam Salud Publica. 26(5):469-70.
Habermann, E. (1989). Palytoxin acts through Na+, K+-ATPase. Toxicon, 27 (11), 1171-1187. https://doi.org/10.1016/0041-0101(89)90026-3.
Júnior OT, Roderjan CN, Neto EC, Ponte MM, Seabra MCP, Knibel MF. (2013). Doença de Haff associada ao consumo de carne de Mylossoma duriventre (pacu-manteiga). Rev. bras. ter. intensiva;25(4):348-351.
Koche, J. C. (2011). Fundamentos de metodologia científica. Editora Vozes. https://doi.org/10.1590/S1517-97022003000100005
Liu C, Wang H, Zhu C, et al. (2018). Diagnostic and Differential Diagnostic Significance of Laboratory Markers in Crayfish Associated Rhabdomyolysis. Ann Clin Lab Sci, 48, 146−51.
Lüdke, M., & André, M. E. D. A. (1986). Pesquisa em educação: abordagens qualitativas. UPU. https://edisciplinas.usp.br/pluginfile.php/4091392/mod_resource/content/1/Lud_And_cap3.pdf.
Patocka, J.; Gupta, R.C.; Wu, Q.-H.; Kuca, K. (2015). Toxic Potential of Palytoxin. Journal of Huazhong University of Science and Technology, 35, 773-780. Doi: 10.1007/s11596-015-1505-3.
Pei, LI Xiao Yan, LU Shuang Shuang, LIU Zhe, WANG Rui#, LU Xuan Cheng#, and LU Kai#. (2019). The Emergence, Epidemiology, and Etiology of Haff Disease. Biomed Environ Sci, 32(10): 769-778. Chinese Center for Disease Control and Prevention, Beijing 102206, China. Disponível em: https://www.sciencedirect.com/science/article/pii/S0895398820300404.
Pereira, A. S., Shitsuka, D. M. S., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. UAB/NTE/UFSM. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1. Acesso em: 28 março 2020.
Qian J, Sha D. (2018). Haff disease complicated by acute lung injury after crayfish consumption: a case report. Clin Toxicol (Phila), 56(6), 449−51.
Rosa, Nuno Guimarães, et al. (2005)."Rhabdomyolysis." Acta médica portuguesa, 18.4: 271-81. Disponível em: https://comum.rcaap.pt/bitstream/10400.26/35943/1/2004%20-Rhabdomyolysis.pdf.
Ses-Pe. Secretaria Estadual de Saúde de Pernambuco (2021). NOTA INFORMATIVA-SES - SEVS - Secretaria de Vigilância em Saúde-Nº 01/05.04.2021. Disponível em: https://12ad4c92-89c7-4218-9e11-0ee136fa4b92.filesusr.com/ugd/3293a8_b73c5c9b318b4a3ebdc0faf4a68ebc7c.pdf.
Sauviat, M.-P. (1992). Palytoxin: characterization of mode of action in excitable cells P.M. Conn (Ed.), Methods in Neurosciences, vol. 8, Neurotoxins, Academic Press, San Diego, CA, USA, pp. 332-346.
Vale, P. (2004). Biotoxinas marinhas. RPCV, 99 (549) 03-18, 2004.
Yang WX, Fan KL, Leung LP. (2018). A cluster of patients with rhabdomyolysis after eating crayfish. CJEM, 20, S48−S50.
Yin, R. K. (2014). Estudo de caso: planejamento e métodos (5°). Bookman.
Zu Jeddeloh B. Haffkrankheit. (1939). Ergeb Inn Med Kinderheilkd. 57:138-82.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Gabriella de Almeida Campos; Sabrina Jurema da Rocha Dantas; Emanuel Guilherme de Almeida Carvalho; Rafael Vinicius de Almeida Tabosa; Elvys Blayne Sales de Souza; Andrezza Thaís da Silva Lino; Magnúcia de Lima Leite; Carmem Lúcia Carneiro Leão de Biase; Sura Amélia Barbosa Felix Leão; Valtuir Barbosa Felix; Euclides Maurício Trindade-Filho; José Claudio da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
